These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11668517)

  • 1. Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients.
    Kappler M; Köhler T; Kampf C; Diestelkötter P; Würl P; Schmitz M; Bartel F; Lautenschläger C; Rieber EP; Schmidt H; Bache M; Taubert H; Meye A
    Int J Cancer; 2001 Nov; 95(6):360-3. PubMed ID: 11668517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
    Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A
    Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
    Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
    Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
    Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
    Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma.
    Würl P; Kappler M; Meye A; Bartel F; Köhler T; Lautenschläger C; Bache M; Schmidt H; Taubert H
    Lancet; 2002 Mar; 359(9310):943-5. PubMed ID: 11918915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
    He XF; Wen DG; Hou JQ; He J; Cen JN
    Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
    Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
    Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
    Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
    Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
    Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
    J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression level of wild-type survivin in gastric cancer is an independent predictor of survival.
    Meng H; Lu CD; Sun YL; Dai DJ; Lee SW; Tanigawa N
    World J Gastroenterol; 2004 Nov; 10(22):3245-50. PubMed ID: 15484293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
    Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
    Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of survivin and TERT in soft-tissue sarcoma.
    Daidone MG; Porta CD; Pilotti S; Zaffaroni N
    Lancet; 2002 Sep; 360(9336):877. PubMed ID: 12243951
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic significance of survivin splicing variants in expression gastric cancer].
    Meng H; Dai DJ; Lu CD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):234-6. PubMed ID: 16167236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).
    Ling X; Yang J; Tan D; Ramnath N; Younis T; Bundy BN; Slocum HK; Yang L; Zhou M; Li F
    Lung Cancer; 2005 Sep; 49(3):353-61. PubMed ID: 15936846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
    Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
    Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.
    Mahotka C; Krieg T; Krieg A; Wenzel M; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
    Int J Cancer; 2002 Jul; 100(1):30-6. PubMed ID: 12115583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer.
    Ikeguchi M; Kaibara N
    Int J Mol Med; 2001 Dec; 8(6):661-6. PubMed ID: 11712083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
    Meng H; Lu C; Mabuchi H; Tanigawa N
    Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.